Injectable Folic Acid and Hydroxocobalamin Recalled Due to Sterility Concerns
Olympia Compounding Pharmacy is recalling 2,441 vials of Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL injectable due to lack of sterility assurance. The affected vials were distributed nationwide, in Puerto Rico, and the US Virgin Islands.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II sterility assurance failure on injectable medication. While sterility issues on injectables pose serious risk of infection, no illnesses or injuries are reported in the source. The recall meets the rubric criterion for Score 3: a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Olympia Compounding Pharmacy dba Olympia Pharmaceuticals is recalling 2,441 vials of Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL multi-dose 30 mL vials (NDC 73198-0112-30). These are prescription injectable products used to supplement folic acid and vitamin B12 (hydroxocobalamin).
The recall was initiated due to lack of assurance of sterility. Sterility is critical for injectable medications; a non-sterile injectable could introduce harmful bacteria or microorganisms directly into the bloodstream, potentially causing serious infections or other serious health complications.
The recalled vials were distributed nationwide in the United States, Puerto Rico, and the US Virgin Islands. The affected lots are L24007 (beyond-use date 6/7/2022) and B24017-22 (beyond-use date 8/17/2022). The manufacturer is located at 6700 Conroy Road, Suite 155, Orlando, Florida 32835.
The recalled product
- Product
- Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0112-30
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Category
- Drug — Injectable
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: L24007 BUD: 6/7/2022
- B24017-22 BUD: 8/17/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27